Contact: John J. Viscogliosi, Raymedica (952) 885-0500
Raymedica® Releases 1st of a 4-Book Series on “Nucleus Arthroplasty™
in Spinal Care.”
MINNEAPOLIS, September 25 - Raymedica, a medical device company
located in Minneapolis, Minnesota, announced that the first of a four-book
series entitled, “Nucleus Arthroplasty in Spinal Care” will
be released at the North American Spine Society (NASS) 21st Annual Meeting
being held in Seattle, WA, September 27-29, 2006. This complimentary
publication will be made available at Raymedica Booth # 413.
Raymedica has jointly produced and published “Nucleus Arthroplasty
in Spinal Care” with noted physician authors: Dr. med. univ. Rudolph
Bertagnoli, Reginald J. Davis, MD, FACS, Federico P. Girardi, MD and
Alexander R. Vaccaro, MD. This resource, which is referred to as “NASC
Book 1,” lays the foundation for the remaining series by providing
expert counsel on key subject matter, which explores nucleus arthroplasty
and how it will impact non-fusion spine surgery.
“The release of the “Nucleus Arthroplasty in Spinal Care”
series marks a further step forward for what is already a very successful
year for Raymedica,” said John J. Viscogliosi, Chairman and CEO
of Raymedica. “The noted physician authors, whose initiative it
was to develop this series, are to be congratulated for all their hard
work in seeing the project from inception to release. This publication
provides spine surgeons and our industry colleagues with unparalleled
access to the emerging technology of nucleus arthroplasty.”
The series of publications is expected to be exceedingly popular as
more and more noted authors are submitting monographs for upcoming issues
in the series, and more readers are accessing the completed works. These
publications are free and available for download at www.nucleusarthroplasty.com.
About Raymedica, LLC.
Raymedica, LLC, based in Minneapolis, Minnesota, is the Pioneer in Nucleus
Arthroplasty having developed the world’s first nucleus replacement
device in 1996. Raymedica develops, manufactures and markets medical
device systems designed to treat patients with degenerative disc disease
that have been unresponsive to non-surgical treatment. Raymedica’s
products are currently available in many countries worldwide, but are
limited to investigational use only in the United States. For more information,
visit the Company’s website at http://www.raymedica.com.
> Back to Press Releases